M. Fontanillas

1.4k total citations
14 papers, 671 citations indexed

About

M. Fontanillas is a scholar working on Oncology, Hematology and Cancer Research. According to data from OpenAlex, M. Fontanillas has authored 14 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Hematology and 4 papers in Cancer Research. Recurrent topics in M. Fontanillas's work include Multiple Myeloma Research and Treatments (4 papers), Medical Imaging Techniques and Applications (3 papers) and Breast Cancer Treatment Studies (3 papers). M. Fontanillas is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Medical Imaging Techniques and Applications (3 papers) and Breast Cancer Treatment Studies (3 papers). M. Fontanillas collaborates with scholars based in Spain. M. Fontanillas's co-authors include Montserrat Muñoz-Mateu, Pilar Paredes, Françesca Pons, Joan Duch, David Fuster, Gorane Santamaría, Martín Velasco, T Castel, Begoña Mellado and J Garcı́a-Conde and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and Leukemia.

In The Last Decade

M. Fontanillas

14 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Fontanillas Spain 11 268 244 179 175 170 14 671
Vittorio Silingardi Italy 12 85 0.3× 342 1.4× 106 0.6× 115 0.7× 80 0.5× 28 619
Christoph E. Heilig Germany 11 66 0.2× 135 0.6× 117 0.7× 265 1.5× 136 0.8× 32 547
Sophie Derenne France 8 72 0.3× 362 1.5× 64 0.4× 418 2.4× 338 2.0× 11 780
Siobhan Ng Australia 12 169 0.6× 355 1.5× 77 0.4× 119 0.7× 45 0.3× 33 708
Hervé Watier France 9 179 0.7× 127 0.5× 30 0.2× 138 0.8× 64 0.4× 10 594
Unn‐Merete Fagerli Norway 13 80 0.3× 278 1.1× 59 0.3× 286 1.6× 261 1.5× 33 744
M. M. Uttenreuther-Fischer Germany 13 123 0.5× 198 0.8× 67 0.4× 201 1.1× 101 0.6× 24 542
Carrie Brownstein United States 12 46 0.2× 269 1.1× 159 0.9× 346 2.0× 174 1.0× 32 699
Kathleen Kemmer United States 9 175 0.7× 86 0.4× 74 0.4× 151 0.9× 62 0.4× 14 598
Justus Duyster Germany 8 101 0.4× 145 0.6× 71 0.4× 144 0.8× 55 0.3× 11 490

Countries citing papers authored by M. Fontanillas

Since Specialization
Citations

This map shows the geographic impact of M. Fontanillas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Fontanillas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Fontanillas more than expected).

Fields of papers citing papers by M. Fontanillas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Fontanillas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Fontanillas. The network helps show where M. Fontanillas may publish in the future.

Co-authorship network of co-authors of M. Fontanillas

This figure shows the co-authorship network connecting the top 25 collaborators of M. Fontanillas. A scholar is included among the top collaborators of M. Fontanillas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Fontanillas. M. Fontanillas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Blancas, Isabel, M. Fontanillas, J. Lao, et al.. (2017). Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice. Clinical & Translational Oncology. 20(7). 862–869. 4 indexed citations
2.
Muñoz-Mateu, Montserrat, Pedro L. Fernández, Pilar Paredes, et al.. (2012). PET/CT with [18F] fluorodeoxyglucose in the assessment of metabolic response to neoadjuvant chemotherapy in locally advanced breast cancer.. PubMed. 56(3). 291–8. 10 indexed citations
3.
Duch, Joan, David Fuster, Montserrat Muñoz-Mateu, et al.. (2009). 18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 36(10). 1551–1557. 87 indexed citations
4.
Fuster, David, Joan Duch, Pilar Paredes, et al.. (2008). Preoperative Staging of Large Primary Breast Cancer With [ 18 F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Compared With Conventional Imaging Procedures. Journal of Clinical Oncology. 26(29). 4746–4751. 208 indexed citations
5.
Mellado, Begoña, María Vela, Dolors Colomer, et al.. (2002). Tyrosinase mRNA in Blood of Patients With Melanoma Treated With Adjuvant Interferon. Journal of Clinical Oncology. 20(19). 4032–4039. 41 indexed citations
6.
Ortega, Juan-José, Josep‐María Ribera, Albert Oriol, et al.. (2001). Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL.. PubMed. 86(6). 586–95. 25 indexed citations
7.
Mellado, Begoña, et al.. (1999). Prognostic significance of the detection of circulating malignant cells by reverse transcriptase-polymerase chain reaction in long-term clinically disease-free melanoma patients.. PubMed. 5(7). 1843–8. 84 indexed citations
8.
9.
Ribera, Josep‐María, Juan-José Ortega, Albert Oriol, et al.. (1998). Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). 83(3). 222–230. 24 indexed citations
10.
Ribera, Josep‐María, Juan-José Ortega, Albert Oriol, et al.. (1998). Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology.. PubMed. 83(3). 222–30. 35 indexed citations
11.
Bladé, Joan, Jesús F. San Miguel, M. Fontanillas, et al.. (1996). Survival of multiple myeloma patients who are potential candidates for early high-dose therapy intensification/ autotransplantation and who were conventionally treated.. Journal of Clinical Oncology. 14(7). 2167–2173. 76 indexed citations
12.
Montserrat, E, J Garcı́a-Conde, Núria Viñolas, et al.. (1996). CHOP vs. ProMACE‐CytaBOM in the treatment of aggressive non‐Hodgkin's lymphomas: long‐term results of a multicenter randomized trial. European Journal Of Haematology. 57(5). 377–383. 28 indexed citations
13.
Bladé, Joan, Montserrat Muñoz-Mateu, M. Fontanillas, et al.. (1996). Treatment of Multiple Myeloma in Elderly People: Long-term Results in 178 Patients. Age and Ageing. 25(5). 357–361. 23 indexed citations
14.
Bladé, Joan, Jesús F. San Miguel, J Garcı́a-Conde, et al.. (1993). Treatment of melphalan-resistant multiple myeloma with vincristine, BCNU, doxorubicin, and high-dose dexamethasone (VBAD). European Journal of Cancer. 29(1). 57–60. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vittorio Silingardi Breakdown of academic impact, for papers by Christoph E. Heilig Breakdown of academic impact, for papers by Sophie Derenne Breakdown of academic impact, for papers by Siobhan Ng Breakdown of academic impact, for papers by Hervé Watier Breakdown of academic impact, for papers by Unn‐Merete Fagerli Breakdown of academic impact, for papers by M. M. Uttenreuther-Fischer Breakdown of academic impact, for papers by Carrie Brownstein Breakdown of academic impact, for papers by Kathleen Kemmer Breakdown of academic impact, for papers by Justus Duyster
Rankless by CCL
2026